2 Followers on Owler
Remix is a Massachusetts-based biotechnology company that researches and develops novel small-molecule therapies for the treatment of cancer, CNS, and genetic diseases... Read more
OverviewCompetitorsFundingNews & Insights
Remix is a Massachusetts-based biotechnology company that researches and develops novel small-molecule therapies for the treatment of cancer, CNS, and genetic diseases... Read more
Remix Therapeutics President & CEO: Peter Smith

President & CEO

Peter Smith

CEO Approval Rating

90/100

2018

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$211M

News

Conference Presentation
Feb 27, 2025
Benzinga
Remix Therapeutics Announces Participation in Leerink Global Healthcare Conference

Remix Therapeutics Competitors

1Arrakis Therapeutics
2Skyhawk Therapeutics
3Translate Bio
Unlock more competitors

Trending Companies